Several studies have shown that CRT and its fragments exhibit anti-tumor effects in animal models (6, 16, 22), which is attributed to the so-called vasostatin activity of CRT N domain (1–180) (6) and other immunobiological roles of CRT (7–9). This evidence concerns the gene CALR and neoplasm.